Skip to content
2000
Volume 5, Issue 2
  • ISSN: 1574-8898
  • E-ISSN:

Abstract

Alzheimer's disease (AD) is rapidly grooving incidence that affects millions of people worldwide, therefore there is an immediate need for its' early and accurate diagnosis. Many research studies have been performed on possible accurate and reliable diagnostic biomarkers of AD. This review study provides an overview on the cerebrospinal fluid (CSF) proteins that are used as biochemical markers for the early diagnosis of AD and their future prospects, as well as relevant patents.

Loading

Article metrics loading...

/content/journals/prn/10.2174/157488910791213194
2010-06-01
2024-10-12
Loading full text...

Full text loading...

/content/journals/prn/10.2174/157488910791213194
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test